Lymphocytic Choriomeningitis Virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses
Journal of Neuroimmunology, ISSN: 0165-5728, Vol: 194, Issue: 1, Page: 70-82
2008
- 71Citations
- 115Usage
- 41Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations71
- Citation Indexes71
- 71
- CrossRef61
- Usage115
- Abstract Views115
- Captures41
- Readers41
- 41
Article Description
In response to invading pathogens, Toll-like receptors (TLR) play a critical role in the initiation of the innate immune response, which can be either beneficial or detrimental to the host. In the present study, we demonstrated that central nervous system (CNS) glial cells are activated by Lymphocytic Choriomeningitis Virus (LCMV) in a TLR2-MyD88/Mal-dependent manner. Specifically, in response to LCMV, both astrocytes and microglial cells isolated from wild-type (WT) mice produced chemokines, such as MCP-1, RANTES and TNF-α. Similar responses occurred in TLR3 KO and TLR4 KO glial cells. In striking contrast, both astrocytes and microglial cells isolated from mice deficient in TLR2, MyD88, and Mal did not produce any of these chemokines. In addition, LCMV infection of glial cells induced up-regulation of TLR2, MHC class-I and II, CD40, CD86 in a MyD88-dependent manner. These results define a functional role for TLR signaling in viral infection-induced activation of CNS glial cells as well as for the immunopathology in the CNS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0165572807004304; http://dx.doi.org/10.1016/j.jneuroim.2007.11.018; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=39849106737&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/18295350; https://linkinghub.elsevier.com/retrieve/pii/S0165572807004304; https://escholarship.umassmed.edu/gsbs_sp/1388; https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2387&context=gsbs_sp; http://www.jni-journal.com/article/S0165-5728(07)00430-4/abstract; http://linkinghub.elsevier.com/retrieve/pii/S0165572807004304; https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=http%3A%2F%2Fwww.jni-journal.com%2Farticle%2FS0165-5728%2807%2900430-4%2Fabstract&rc=0&code=jni-site; http://acw.elsevier.com/SSOCore?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.jni-journal.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253Daaa1t4Z98sKIO82kemKxv%2526MAID%253Dndcm7yCQfdCuoIcAtieLwQ%25253D%25253D%2526SERVER%253DWZ6myaEXBLGvmNGtLlDx7g%25253D%25253D%2526ORIGIN%253D427638727%2526RD%253DRD; http://acw.elsevier.com/SSOCore/?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.jni-journal.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253Daaa1t4Z98sKIO82kemKxv%2526MAID%253Dndcm7yCQfdCuoIcAtieLwQ%25253D%25253D%2526SERVER%253DWZ6myaEXBLGvmNGtLlDx7g%25253D%25253D%2526ORIGIN%253D427638727%2526RD%253DRD; https://secure.jbs.elsevierhealth.com/action/consumeSsoCookie?redirectUri=http%3A%2F%2Fwww.jni-journal.com%2Faction%2FconsumeSharedSessionAction%3FJSESSIONID%3Daaa1t4Z98sKIO82kemKxv%26MAID%3Dndcm7yCQfdCuoIcAtieLwQ%253D%253D%26SERVER%3DWZ6myaEXBLGvmNGtLlDx7g%253D%253D%26ORIGIN%3D427638727%26RD%3DRD&acw=&utt=
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know